Madison, WI, United States of America

Zachary A Pfieffer



Average Co-Inventor Count = 4.0

ph-index = 3

Forward Citations = 94(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations in Biosensing: The Impact of Zachary A. Pfieffer

Introduction: Zachary A. Pfieffer, based in Madison, WI, is an accomplished inventor with a notable portfolio that includes three patents. His innovative work primarily focuses on the development of binding proteins that serve as biosensors, significantly enhancing the way we detect and analyze biological substances.

Latest Patents: Pfieffer's most recent patents revolve around the concept of mutated binding proteins incorporated with thiol groups. These compositions are designed to couple with sensor surfaces, leading to the creation of analyte biosensor devices. His inventions cater to various applications, demonstrating their utility both in vitro and in vivo. This pioneering approach represents a significant advancement in the field of biosensing, contributing to improved technologies for health monitoring and diagnostics.

Career Highlights: Pfieffer is currently employed at Becton Dickinson and Company, a leading global medical technology firm renowned for its innovation in the medical device industry. His role at the company enables him to apply his expertise in the field of biosensors, driving forward cutting-edge research and development initiatives.

Collaborations: Throughout his career, Pfieffer has collaborated with notable colleagues, including J. Bruce Pitner and Jason E. Gestwicki. These partnerships highlight the collaborative spirit of innovation, fostering an environment where creativity and technical advancements can thrive.

Conclusion: Zachary A. Pfieffer's contributions to the field of biosensing through binding proteins underscore the importance of innovation in medical diagnostics. His patents demonstrate a commitment to advancing technology that can significantly enhance our understanding and detection of biological analytes. As he continues to work at Becton Dickinson and Company, Pfieffer remains a key figure in the evolution of biosensor technology, promising exciting developments in the near future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…